Phenotype classification in IBD: Is there an impact on therapy?

Inflammatory Bowel Diseases

Volumn 13, Issue 12, 2007, Pages 1573-1575

  Wolfish, Aaron ^a   Sachar, David ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Biologic therapies; Clinical areas; Clinical trials

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

CROHN DISEASE; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; ENTERITIS; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; ULCERATIVE COLITIS;

HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 38049048714     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20232     Document Type: Review

References (29)

1. Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis. JAMA. 1932;99:1323-1328.
2. Lockhart-Mummery HE, Morson BC. Crohn's disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis. Gut. 1960;1:87-105.
3. Janowitz HD, Lindner AE, Marshak RH. Granulomatous colitis: Crohn's disease of the colon. JAMA. 1965;191:825-828.
4. Farmer RG, Hawk WA, Tumbull RB Jr. Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology. 1975;68:627-635.
5. Greenstein AJ, Lachman P, Sachar DB, et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut. 1988;29:588-592.
6. Sachar DB, Andrews HA, Farmer RG, et al. Proposed classification of patients subgroups in Crohn's disease. Gastroenterol Int. 1992;5:142-154.
7. Gasché C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8-15.
8. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5-36
9. Motil KJ, Grand RJ, Davis-Kraft L, et al. Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology. 1993;105:681-691.
10. Anwar M, Freitas, JL, Mouzas IA, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut. 2006;55;36-58
11. Lenaerts C, Roy CC, Vaillancourt M, et al: High incidence of upper gastrointestinal tract involvement in children with Crohn's disease. Pediatrics. 1989;83:777.
12. Dubinsky MC, Lin YC, Dutridge D, et al. Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression. Am J Gastroenterol. 2006;101:360-367.
13. Amre DK, Lu SE, Costea F, et al. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients. Am J Gastroenterol. 2006;101:645-652
14. Freeman HJ. Age-dependent phenotypic clinical expression of Crohn's disease. J Clin Gastroenterol. 2005;39:774-777.
15. Louis E, Collard A, Oger AF, et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49:777-782.
16. Oostenbrug LE, van Dullemen HM, te Meerman GJ, et al. Clinical outcome of Crohn's disease according to the Vienna classification: disease location is a useful predictor of disease course. Eur J Gastroenterol Hepatol. 2006;18:255-261.
17. Marion JF, Lachman P, Greenstein AJ, et al. Rarity of fistulas in Crohn's disease of the jejunum. Inflamm Bowel Dis. 1995;1:34-36.
18. Sachar DB, Bodian CA, Goldstein ES, et al. Is perianal Crohn's disease associated with intestinal fistulization? Am J Gastroenterol. 2005;100: 1547-1549.
19. Sachar DB. Classification of Crohn's disease: implications for management. In: McLeod RS, Martin F, Sutherland LR, et al, eds. Trends in inflammatory bowel disease therapy. Dordrecht: Kluwer Academic; 1997:93-98.
20. Avidan B, Sakhnini E, Lahat A, et al. Risk factors regarding the need for a second operation in patients with Crohn's disease. Digestion. 2005; 72:248-253.
21. Griffiths AM, Wesson DE, Shandling B, et al. Factors influencing postoperative recurrence of Crohn's disease in childhood. Gut. 1991;32: 491-495.
22. Hellers G, Cortot A, Jewell D, et al. Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology. 1999;116:294-300.
23. Louis E, Collard A, Oger AF, et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49:777-782.
24. Colombel JF. The CARD15 (also known as NOD2) gene in Crohn's disease: are there implications for current clinical practice? Clin Gastroenterol Hepatol. 2003;1:5-9.
25. Radford-Smith G, Pandeya N. Associations between NOD2/CARD15 genotype and phenotype in Crohn's disease - are we there yet? World J Gastroenterol. 2006;12:7097-7103.
26. Brescianini S, Trinh T, Stoll M, et al. IBD5 is associated with an extensive complicated Crohn's disease feature: implications from genotype-phenotype analysis. Gut. 2007;56:149-150.
27. Sachar DB. Genomics and phenomics in Crohn's disease. Gastroenterology. 2002;122:1161-1162.
28. Rubin DT, Kavitt RT. Surveillance for cancer and dysplasia in inflammatory bowel disease. Gastroenterol Clin North Am. 2006;35:581-604.
29. Achkar JP, Dassopoulos T, Silverberg MS, et al. Phenotype-stratified genetic linkage study demonstrates that IBD2 is an extensive ulcerative colitis locus. Am J Gastroenterol. 2006;101:572-580.